Merck’s decision to back out of its $1 billion expansion comes as U.K. investments in life sciences declines. The post Merck backs out of Britain: is the U.K. struggling to retain its life sciences sector? appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credi...| Labiotech.eu
BMO analysts said in a note Monday they were “encouraged” that Genmab’s acquisition “could start to spur broader M&A in the sector.” The post Genmab Strikes $8 Billion Deal for Cancer Treatment Maker Merus appeared first on The Daily Upside.| The Daily Upside
Global science and technology company joins Swift pilot programme, leveraging Broadridge’s API orchestration capabilities for on-demand account visibility across 400+ accounts Broadridge Financial Solutions, Inc., a global Fintech leader, announced that Merck has selected Broadridge to implement Swift’s new Instant Cash Reporting service through its Swift Service Bureau (SSB) and SCORE+ services.... The post Merck Selects Broadridge to Transform Treasury Operations with Real-Time Accoun...| GlobalFinTechSeries